Literature DB >> 7911527

Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels.

D N Burns1, S Landesman, L R Muenz, R P Nugent, J J Goedert, H Minkoff, J H Walsh, H Mendez, A Rubinstein, A Willoughby.   

Abstract

To examine the possible influence of obstetric factors, substance use during pregnancy, and other maternal factors on the relationship between a low maternal CD4+ level and vertical transmission of human immunodeficiency virus type 1 (HIV-1), data were analyzed from the Mothers and Infants Cohort Study, a prospective cohort followed for up to 4 years between 1986 and 1992 in Brooklyn and the Bronx, New York. The overall transmission rate for the cohort was 25.1% (95% confidence interval (CI) = 19.0-31.3). Prenatal CD4+ lymphocyte measurements were available for 162 HIV-seropositive mothers of infants with known infection outcomes. Among mothers who smoked cigarettes after the first trimester, those whose mean prenatal CD4+ level was < 20% had more than a threefold increased risk of transmitting their infection to their infants [relative risk (RR) = 3.30; 95% CI = 1.46-7.44; p = 0.004]. Among mothers who developed premature rupture of membranes, those with a low CD4+ level had a similarly increased risk of vertical transmission (RR = 4.33; 95% CI = 1.78-10.5; p = 0.003). These relative risks were much higher than those for mothers who did not smoke after the first trimester (RR = 1.14; 95% CI = 0.48-2.70; p = 0.76) or have premature rupture of membranes (RR = 1.29; 95% CI = 0.61-2.74; p = 0.50), indicating that these factors modified the effect of CD4+ level on transmission. Among all mothers without regard to CD4+ level, those who experienced preterm premature rupture of membranes were also at greater risk of transmission (RR = 2.24; 95% CI = 1.07-4.69; p = 0.03).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911527

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  13 in total

Review 1.  Preterm prelabor rupture of the membranes: A disease of the fetal membranes.

Authors:  Ramkumar Menon; Lauren S Richardson
Journal:  Semin Perinatol       Date:  2017-08-12       Impact factor: 3.300

2.  Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.

Authors:  Risa M Hoffman; Vivian Black; Karl Technau; Karin Joan van der Merwe; Judith Currier; Ashraf Coovadia; Matthew Chersich
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

Review 3.  Mother-to-child transmission (MTCT) of HIV and drugs of abuse in post-highly active antiretroviral therapy (HAART) era.

Authors:  Vishnudutt Purohit; Rao S Rapaka; David Shurtleff
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-14       Impact factor: 4.147

Review 4.  Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.

Authors:  Judith A Cook
Journal:  Life Sci       Date:  2011-01-08       Impact factor: 5.037

5.  The maternal and child health sites' practices regarding HIV education, counseling, and testing of women of reproductive age in Chicago: barriers to universal implementation.

Authors:  A Rahimian; M Driscoll; D Taylor
Journal:  Matern Child Health J       Date:  1998-03

Review 6.  Risks and benefits of nicotine to aid smoking cessation in pregnancy.

Authors:  D A Dempsey; N L Benowitz
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 7.  Advances in prevention of mother-to-child HIV transmission: the international perspectives.

Authors:  Chokechai Rongkavilit; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2010-10-16       Impact factor: 1.967

Review 8.  Advances in prevention of mother-to-child HIV transmission.

Authors:  Chokechai Rongkavilit; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

9.  German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.

Authors:  Bernd Buchholz; Matthias Beichert; Ulrich Marcus; Thomas Grubert; Andrea Gingelmaier; Annette Haberl; Brigitte Schmied
Journal:  Eur J Med Res       Date:  2009-11-03       Impact factor: 2.175

10.  Human immunodeficiency virus type 1 counseling and testing program in the prenatal setting.

Authors:  A D Bardeguez; T Denny; P Palumbo; Y Wesley; J Oleske; E Connor; G Weiss
Journal:  Infect Dis Obstet Gynecol       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.